Lansoprazole Arrow Lab

Lansoprazole, the active ingredient in Lansoprazole Arrow Lab, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, erosive oesophagitis, and to aid Helicobacter pylori eradication regimens in adult patients.

GNH USA supplies Lansoprazole Arrow Lab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including tertiary care centres and outpatient dispensaries through reliable logistics networks.

Lansoprazole, a proton pump inhibitor, is indicated for several acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal erosion. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication (as part of combination therapy): enhances eradication rates by suppressing gastric acid.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Abdominal pain: discomfort in the stomach area. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Low magnesium levels (hypomagnesemia): can lead to muscle cramps or cardiac arrhythmia.

Before prescribing lansoprazole, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Review concomitant medications: avoid drugs that require acidic pH for absorption. - Monitor for infection: be alert to signs of C. difficile colitis. - Use cautiously in pregnancy: weigh potential benefits against limited data. - Store at ambient temperature: keep below 25°C, in the original pack, protect from moisture.

Lansoprazole may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Atazanavir, nelfinavir, rilpivirine (antiretrovirals): reduced absorption and efficacy. - Ketoconazole, itraconazole (antifungals): decreased bioavailability; separate dosing by at least 2 hours.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: may raise serum levels, observe for toxicity. - Methotrexate: risk of elevated concentrations, check renal function. - Clopidogrel: reduced activation, assess antiplatelet effect.